Tero Aittokallio
PhD
teanai@utu.fi Tykistökatu 6 A Turku ORCID identifier: https://orcid.org/orcid.org/0000-0002-0886-9769 |
Tero Aittokallio received his PhD in Applied Mathematics from the University of Turku in 2001, under the supervision of Prof. Mats Gyllenberg. He then did his post-doctoral training in the Systems Biology Lab at the Institut Pasteur (2006-2007), with Dr. Benno Schwikowski, where he focused on network biology applications using high-throughput experimental assays and network analysis tools such as Cytoscape. In 2007, Dr. Aittokallio launched his independent career as a principal investigator in the Turku Biomathematics Research Group, where he received a five-year appointment as an Academy of Finland Research Fellow (2007-2012). Tero Aittokallio joined Institute for Molecular Medicine Finland (FIMM) as EMBL Group Leader in the fall of 2011, and was selected as Professor of Statistics and Applied Mathematics at University of Turku in 2015.
Aittokallio's research group focuses on developing and applying integrated computational-experimental approaches to tackle biomedical questions, such as how genes function as interaction networks to carry out and regulate cellular processes, how alterations in these networks contribute to complex traits, such as human diseases, and where and how in the disease network one should target to optimally inhibit the disease phenotypes, such as tumor growth.
Computational statistics.
Scientific computing.
- (2014)
- Nature Biotechnology
(A1 Refereed original research article in a scientific journal) - AML Specific Targeted Drugs Identified By Drug Sensitivity and Resistance Testing: Comparison of Ex Vivo Patient Cells with in Vitro Cell LinesCOMPREHENSIVE ASSESSMENT OF BONE MARROW STROMA-DERIVED SOLUBLE FACTORS AND IMPACT ON EX VIVO DRUG SENSITIVITIES OF PRIMARY AML CELLS (2014)
- Blood
(Other publication) - (2014)
- Cancer Research
(Other publication) - (2014)
- Lecture Notes in Computer Science
(A4 Refereed article in a conference publication ) - (2014)
- HaematologicaCancer Research
(Other publication) - Drug set enrichment analysis : A computational approach to identify functional drug sets (2014)
(Other publication) - Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis (2014)
- Journal of Chemical Information and ModelingPLoS ONE
(A1 Refereed original research article in a scientific journal) - (2014)
- Current Pharmaceutical DesignReproductive Sciences
(A1 Refereed original research article in a scientific journal) - Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model (2014)
(A1 Refereed original research article in a scientific journal) - Novel Targeted Therapies for Granulosa Cell Tumors Using High-Throughput Drug Screen of Primary Tumor Cells (2014)
(Other publication)



